1. Home
  2. TAK

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Founded: 1781 Country:
Japan
Japan
Employees: N/A City: N/A
Market Cap: 41.5B IPO Year: N/A
Target Price: $20.00 AVG Volume (30 days): 1.9M
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield: 4.64% Dividend Payout Frequency: Semi-Annual
EPS: 0.36 EPS Growth: -36.02
52 Week Low/High: $13.19 - $17.11 Next Earning Date: 05-09-2024
Revenue: $29,400,909,732 Revenue Growth: 5.69%
Revenue Growth (this year): 2.36% Revenue Growth (next year): -1.92%

Share on Social Networks: